MARASCA, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 4.560
NA - Nord America 3.545
EU - Europa 2.799
SA - Sud America 531
AF - Africa 112
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.565
Nazione #
US - Stati Uniti d'America 3.384
SG - Singapore 2.050
RU - Federazione Russa 1.472
VN - Vietnam 873
CN - Cina 754
BR - Brasile 429
IT - Italia 412
HK - Hong Kong 316
DE - Germania 201
FR - Francia 190
NL - Olanda 164
IN - India 119
CA - Canada 88
GB - Regno Unito 81
JP - Giappone 76
KR - Corea 61
FI - Finlandia 56
CI - Costa d'Avorio 49
PL - Polonia 46
BD - Bangladesh 41
MX - Messico 40
SE - Svezia 39
AR - Argentina 35
IQ - Iraq 33
ES - Italia 29
TH - Thailandia 29
TR - Turchia 28
ID - Indonesia 26
ZA - Sudafrica 26
UA - Ucraina 25
PH - Filippine 24
PK - Pakistan 22
IR - Iran 20
IE - Irlanda 19
AU - Australia 14
CL - Cile 12
UZ - Uzbekistan 12
CO - Colombia 11
JM - Giamaica 11
PY - Paraguay 11
TW - Taiwan 11
PE - Perù 10
AT - Austria 9
EC - Ecuador 9
JO - Giordania 9
MY - Malesia 9
CZ - Repubblica Ceca 8
LT - Lituania 8
GR - Grecia 7
MA - Marocco 7
VE - Venezuela 7
NP - Nepal 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
DZ - Algeria 5
HR - Croazia 5
KE - Kenya 5
TN - Tunisia 5
UY - Uruguay 5
BE - Belgio 4
CH - Svizzera 4
IL - Israele 4
MK - Macedonia 4
NE - Niger 4
AM - Armenia 3
AO - Angola 3
DO - Repubblica Dominicana 3
HN - Honduras 3
QA - Qatar 3
RS - Serbia 3
AF - Afghanistan, Repubblica islamica di 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
CU - Cuba 1
CV - Capo Verde 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
Totale 11.550
Città #
Singapore 1.005
San Jose 702
Moscow 378
Ashburn 338
Hong Kong 305
Chandler 267
Beijing 254
Ho Chi Minh City 235
Santa Clara 183
Hanoi 182
Hefei 180
Amsterdam 137
Napoli 122
Lauterbourg 103
Los Angeles 90
Boston 83
The Dalles 76
Millbury 67
Lawrence 65
Naples 63
Tokyo 62
Munich 58
Redondo Beach 57
Des Moines 55
Buffalo 43
Frankfurt am Main 43
Da Nang 38
Ottawa 38
New York 37
Nanjing 35
Seoul 34
Dallas 30
Warsaw 29
Helsinki 28
Kochi 28
Haiphong 27
São Paulo 27
Orem 26
Seattle 25
Council Bluffs 23
Brooklyn 22
Düsseldorf 22
Dong Ket 20
Montreal 19
Mumbai 19
Baghdad 18
Chicago 18
Princeton 18
Rome 18
Denver 17
Phoenix 17
Chennai 16
London 16
Houston 15
Milan 15
Turku 15
Wilmington 15
Atlanta 14
Biên Hòa 14
Falkenstein 14
Redwood City 14
Toronto 14
Boardman 13
Guangzhou 13
Hải Dương 13
Johannesburg 13
Porto Alegre 13
Stockholm 13
Mexico City 12
Nuremberg 12
Poplar 11
Rio de Janeiro 11
San Francisco 11
Wroclaw 11
Bangkok 10
Belo Horizonte 10
Portsmouth 10
Tashkent 10
Woodbridge 10
Amman 9
Dhaka 9
Dublin 9
Washington 9
Ankara 8
Bengaluru 8
Brasília 8
Can Tho 8
Jiaxing 8
New Delhi 8
Salerno 8
Sorocaba 8
Thái Bình 8
Asunción 7
Hebei 7
Istanbul 7
Lahore 7
Lima 7
Quận Ba 7
San Juan 7
Shenyang 7
Totale 6.308
Nome #
Effectiveness of supplementation with myo-inositol, folic acid and liposomal magnesium in male insulin-resistant patients with acne 300
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case 179
Anti-TNF-α therapy modulates mTORC1 signalling in hidradenitis suppurativa 175
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 174
An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis Suppurativa: our experience 161
Mucocutaneous involvement of the genital and perianal skin during isotretinoin therapy 156
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review 155
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool? 150
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: A review of the literature 150
Efficacy and tolerability of a spray product containing hydroxypropyl chitosan, Climbazole and Piroctone olamine, applied twice weekly for the treatment of the Pitiriasis Versicolor 146
Chemotherapy-induced periungual pyogenic granuloma: epidemiology and recurrence rates in our experience 142
Isotretinoin in acne treatment during the coronavirus disease 2019 (COVID-19): A retrospective analysis of adherence to therapy and side effects 139
A case of a primary cutaneous diffuse large B-cell lymphoma, leg type 139
Assessment of the Combined Efficacy of Needling and the Use of Silicone Gel in the Treatment of C-Section and Other Surgical Hypertrophic Scars and Keloids 138
A case of Axillary Hidradenitis suppurativa treated with topical tacrolimus 134
Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: Evaluation of nutritional status and its association with severity of disease 134
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 133
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 133
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears 132
Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report 131
A misdiagnosed case of furuncular myiasis in an Italian traveler returning from Kenya 131
Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients 129
Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case 129
Valutazione dell'efficacia di un coadiuvante topico a base di argento micronizzato, zinco acetato e acido laurico nel trattamento dell'acne lieve-moderata 127
Photodynamic Therapy and Skin Appendage Disorders: A Review 127
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 126
Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients’ quality of life 126
Acne Smart Club: An Educational Program for Patients with Acne 126
A case of Zoon Balanitis in an immune-competent teenager 126
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies? 126
Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience 125
Ixekizumab: an efficacious treatment for both psoriasis and hidradenitis suppurativa 125
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature 124
Low dose oral corticosteroids, microneedling, and topical 5-fluorouracil: A novel treatment for recalcitrant pediatric vitiligo 124
Long-term clinical safety of Clindamycin and Rifampicin combination for the treatment of Hidradenitis Suppurativa: strategy to reduce side effects, improving patients' compliance 123
A dermatological questionnaire for general practitioners with a focus on hidradenitis suppurativa 123
A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23 123
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy 122
New insights into mechanism of Notch signalling in hidradenitis suppurativa 122
Acitretin may improve symptoms and exudation in patients affected by elephantiasis nostras verrucosa: Report of a case 122
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 122
Hyperbaric oxygen therapy (HBOT) can improve the effectiveness of adalimumab in Hidradenitis Suppurativa: report of a case 121
Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results 120
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study 119
The pharmacology of antibiotic therapy in hidradenitis suppurativa 117
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al 116
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb 116
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? 115
Adult atopic dermatitis: new and emerging therapies 115
Chondroid Syringoma: an asymptomatic benign tumour 114
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects 111
Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review 109
Unconventional therapies for hidradenitis suppurativa 108
Reply to 'Burnout and professional quality of life in dermatologists' 107
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis 107
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab" 105
Marjolin's ulcer in a paraplegic man: A further example of the immunocompromised district 104
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis? 104
May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions? 103
Step by step surgery for Hidradenitis Suppurativa 102
Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome 102
Hidradenitis suppurativa flares following COVID-19 vaccination: A case series 102
A case of erythrodermic psoriasis successfully treated with guselkumab 101
A case of acne fulminans successfully treated with photodynamic therapy 101
Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HS 100
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine 100
Frequency of allergic contact dermatitis in hidradenitis suppurativa patients 99
A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus 96
Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity 96
Hidradenitis Suppurativa: Where We Are and Where We Are Going 96
Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al 95
Chronic cutaneous ulcers management in dermatologic department during COVID-19 era 95
A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab 92
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience 92
Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes" 92
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast 92
Human Microbiome: Composition and Role in Inflammatory Skin Diseases 91
Skin Needling in Combination with Antimicrobial Peptides for the Treatment of Keloids: A Novel Perspective Proposal and Approach for Skin Scars 90
Onset of vitiligo in a psoriasis patient on ixekizumab 90
Hair removal and deodorants in hidradenitis suppurativa: an online survey on patients' habits 89
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa' 89
Quality of life in people living with patients suffering from hidradenitis suppurativa 84
Disfiguring Hidradenitis Suppurativa of the Face 84
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic 83
A Subungual Exostosis Mimicking a Periungual Granuloma in a 9-Year-Old Boy: An Unexpected Dermoscopic Pattern 83
Coronavirus disease and dermatology: current and future challenges 82
Insulin resistance, mTOR and hidradenitis suppurativa 81
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al 78
Neoadjuvant use of methotrexate in eosinophilic angiocentric fibrosis of upper lip and hard palate: A case report 77
A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa? 74
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? 72
Update on pathogenesis of hidradenitis suppurativa 72
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa 71
Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy 69
Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series 69
Topical oil formulation of plant extracts and vitamins as effective treatment for stretch marks and xerosis—An observational longitudinal study 69
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 66
Dietary Intervention: An Essential Part of the Management of Patients Affected by Hidradenitis Suppurativa 64
Comment on ‘The effects of isotretinoin therapy on serum homocysteine, folate and vitamin B12 levels in patients with acne’: may retinoids be useful to treat hyperhomocysteinemia found in patients affected by hidradenitis suppurativa? 62
Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting 58
Totale 11.240
Categoria #
all - tutte 37.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/2022497 5 14 3 1 5 15 6 14 79 53 103 199
2022/2023792 88 38 33 24 104 80 8 77 124 138 54 24
2023/2024622 29 108 72 40 29 77 18 78 16 10 92 53
2024/20253.335 164 148 20 25 117 168 299 236 236 398 1.207 317
2025/20265.942 660 428 622 515 1.058 273 800 326 758 382 110 10
Totale 11.773